Fingerprint
Dive into the research topics of 'Randomized phase III trial results of Panitumumab, a fully human anti-epidermal growth factor receptor monoclonal antibody, in metastatic colorectal cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically